Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2012
11/07/2012CN101972226B Veterinary doxycycline hydrochloride injection and preparation method thereof
11/07/2012CN101904869B Method for preparing animal semen freeze-dried powder
11/07/2012CN101854931B Therapeutic composition containing amlodipine nicotinate and statins
11/07/2012CN101843571B Multiple emulsion for loading tea polyphenol and preparation method thereof
11/07/2012CN101810674B Chinese medicinal composition for enhancing immunity, and preparation method thereof
11/07/2012CN101784263B Extended release formulation of nevirapine
11/07/2012CN101773465B Polymer micelle medicine carrying system using amino acid as stabilizing agent
11/07/2012CN101772342B Composition for manufacturing orally disintegrating dosage form to protect coating layer of active substance
11/07/2012CN101732695B Compound of brain protein hydrolyzate and maleic acid and method for preparing same
11/07/2012CN101732319B Landiolol hydrochloride active ingredient-containing medicinal composition for injection and preparation method thereof
11/07/2012CN101721383B Enalapril maleate tablet and preparation method thereof
11/07/2012CN101708173B Soft capsule and application thereof
11/07/2012CN101646420B Solid preparation comprising alogliptin and pioglitazone
11/07/2012CN101548960B High-dissolution oral bifendate capsule and preparation method thereof
11/07/2012CN101547884B Granulated sorbitol and method for the preparation thereof
11/07/2012CN101541310B Powder formulation for valganciclovir
11/07/2012CN101536994B Method for preparing hybrid nanofiber membrane capable of loading drug
11/07/2012CN101495092B Cosmetic compositions with encapsulated pigments and a method for using
11/07/2012CN101461853B Chinese medicine granular formulation for relieving cough, dispelling phlegm and calming panting and preparation method thereof
11/07/2012CN101380313B Famotidine high density type gastric retention osmotic pump controlled release preparation and preparation method thereof
11/07/2012CN101291656B Preparation with accurate dose-dividing function
11/07/2012CN101264121B Blood fat reducing health products and preparation
11/07/2012CN101217946B Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their pharmaceutical use
11/07/2012CN101203245B Injection formula for RNA
11/07/2012CN101120926B Freezing-dried preparation containing voriconazole and its preparation method
11/07/2012CN101074223B Versulin derivative and its use in treatment of diabetes and its complication
11/07/2012CN101066260B Coenzyme Q10 emulsion and its freeze dried emulsion and their preparation process
11/07/2012CN101062024B Pronin medicinal composition and its preparing method
11/07/2012CN101057834B Solid preparation comprising enteric solid dispersion
11/06/2012US8304498 Medical devices comprising a modified polyamide
11/06/2012US8304405 Combination of azelastine and ciclesonide for nasal administration
11/06/2012US8304220 Bone semi-permeable device
11/06/2012US8303995 Nitrite formulations and their use as nitric oxide prodrugs
11/06/2012US8303992 Dried formulations of nanoparticle-coated capsules
11/06/2012US8303991 Method of making particles for use in a pharmaceutical composition
11/06/2012US8303990 Nanophoresis by placing magnetic nanoparticles conjugated with lipids, proteins, hormones, antioxidants, free radical scavengers into a middle region of an ear; magnetically driving particles through a membrane into the fluid of the inner ear; diagnosis or prophylaxis of ear disorders
11/06/2012US8303989 Compositions and methods for increasing the oral absorption of antimicrobials
11/06/2012US8303988 Antifungal once-a-day product, use and formulation thereof
11/06/2012US8303987 Pharmaceutical compositions comprising fluvastatin
11/06/2012US8303986 Hydrophilic/lipophilic polymeric matrix dosage formulation
11/06/2012US8303985 Skin treatment compositions containing copper-pigment complexes
11/06/2012US8303984 Skin treatment compositions containing copper-pigment complexes
11/06/2012US8303983 Targeted liposomal drug delivery system
11/06/2012US8303981 Fragmented polymeric compositions and methods for their use
11/06/2012US8303976 Inorganic shaped bodies and methods for their production and use
11/06/2012US8303975 Implants for administering substances and methods of producing implants
11/06/2012US8303974 Drug delivery system for the prevention of cerebral vasospasm
11/06/2012US8303972 Hydrogel bioscaffoldings and biomedical device coatings
11/06/2012US8303970 Polyamide-based powder and its use for obtaining an antibacterial coating
11/06/2012US8303967 mixture of calcium phosphate, collagen and glass; reabsorption
11/06/2012US8303942 Composition for hair
11/06/2012US8303937 Dendritic polymers and magnetic resonance imaging contrast agent employing the same
11/06/2012US8303574 Adhesive and peripheral systems and methods for medical devices
11/06/2012US8303573 Medical or veterinary digestive tract utilization systems and methods
11/06/2012CA2661987C Process for the preparation of sevelamer hydrochloride and formulation thereof
11/06/2012CA2607250C Polyethylene glycol colonic purgative composition
11/06/2012CA2594711C Somatostatin analogue formulations
11/06/2012CA2563609C Pharmaceutical compositions for acute glucocorticoid therapy
11/06/2012CA2529515C Stable beadlets of lipophilic nutrients
11/06/2012CA2518528C Chewing gum in the form of multi-layer tablets
11/06/2012CA2497973C Antibiotic microspheres for treatment of infections and osteomyelitis
11/06/2012CA2493083C Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
11/06/2012CA2412790C Liposomal antineoplastic drugs and uses thereof
11/06/2012CA2378751C Stable factor viii compositions
11/06/2012CA2365532C Arpe-19 as a platform cell line for encapsulated cell-based delivery
11/01/2012WO2012149454A2 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use
11/01/2012WO2012149451A1 Intravascular delivery of nanoparticle compositions and uses thereof
11/01/2012WO2012149411A1 Controlled release of immunosuppressants from synthetic nanocarriers
11/01/2012WO2012149405A2 Tolerogenic synthetic nanocarriers for regulating innate immune responses
11/01/2012WO2012149393A2 Tolerogenic synthetic nanocarriers for antigen-specific deletion of t effector cells
11/01/2012WO2012149376A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
11/01/2012WO2012149326A1 Layer processing for pharmaceuticals
11/01/2012WO2012149301A2 Tolerogenic synthetic nanocarriers for inducing regulatory b cells
11/01/2012WO2012149287A1 Solvent cast film sustained release latanoprost implant
11/01/2012WO2012149282A2 Tolerogenic synthetic nanocarriers for generating cd8+regulatory t cells
11/01/2012WO2012149278A1 Sustained release latanoprost implant
11/01/2012WO2012149268A1 Tolerogenic synthetic nanocarriers for allergy therapy
11/01/2012WO2012149265A2 Tolerogenic synthetic nanocarriers to reduce cytotoxic t lymphocyte responses
11/01/2012WO2012149259A1 Tolerogenic synthetic nanocarriers to reduce antibody responses
11/01/2012WO2012149255A2 Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteins
11/01/2012WO2012149252A2 Tolerogenic synthetic nanocarriers
11/01/2012WO2012149247A2 Tolerogenic synthetic nanocarrier compositions with transplantable graft antigens and methods of use
11/01/2012WO2012149116A2 Liposomal vancomycin for the treatment of mrsa infections
11/01/2012WO2012149045A2 Liposomal formulations
11/01/2012WO2012148953A1 Solid compositions for pharmaceutical use
11/01/2012WO2012148799A1 Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same
11/01/2012WO2012148684A1 Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
11/01/2012WO2012148225A2 Sustained-release pharmaceutical composition comprising donepezil or pharmaceutically acceptable salt thereof having improved dissolution stability and method for manufacturing the same
11/01/2012WO2012148181A2 Composition for the controlled-release of drugs
11/01/2012WO2012147986A1 Stable pharmaceutical composition
11/01/2012WO2012147873A1 Coating composition with superior oral disintegration characteristics
11/01/2012WO2012147842A1 Beautiful-skin-promoting agent and use thereof
11/01/2012WO2012147831A1 Method for manufacturing phosphonocrotonic acid derivative
11/01/2012WO2012147714A1 NANOPARTICLES CONTAINING pH-RESPONSIVE PEPTIDE
11/01/2012WO2012147660A1 Rapidly dissolving oral tablet
11/01/2012WO2012147584A1 Suspended lotion containing imidazole-type anti-fungal agent
11/01/2012WO2012147351A1 Powdered starting material, bottle cap, and container comprising said bottle cap
11/01/2012WO2012147101A2 Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
11/01/2012WO2012147099A1 Pharmaceutical compositions of levodopa, carbidopa and entacapone
11/01/2012WO2012147055A1 Process and apparatus for obtaining a solid form of material
1 ... 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 ... 2991